Oncology and Gastrointestinal Malignancies
Uppsala University, through the Department of Immunology, Genetics and Pathology, is involved in clinical research on colorectal cancer and neuroendocrine neoplasms, with attention to disease control, tumour recurrence, and treatment response in advanced and metastatic settings.
- Colorectal cancer
- Neuroendocrine neoplasms (NENs)
- Metastatic disease
- Recurrence-free survival
The oncology portfolio includes research on surgical and locoregional management as well as biologically targeted approaches for advanced tumour disease.
Endocrinology and Metabolic Disease
Clinical studies at the sponsor address type 2 diabetes, with interest in early disease progression and treatment strategies that compare glucose-lowering approaches in patients at risk of long-term complications.
- Type 2 diabetes
- Early diabetes
- Metformin
- SGLT2 inhibitors
Research in this area focuses on metabolic control and outcomes relevant to disease progression.
Vascular Medicine
The sponsor funds research on small abdominal aortic aneurysm surveillance, including studies examining aneurysm growth in patients without diabetes and the role of medical therapy in slowing progression.
- Abdominal aortic aneurysm (AAA)
- Active surveillance
- Aneurysm growth
- Vascular risk reduction
This work is centred on preventing enlargement and supporting monitoring in patients with small aneurysms.
Women’s Health and Supportive Care
Clinical research also includes management of vulvovaginal atrophy symptoms in women with breast cancer, with attention to sexual function and symptom relief in the context of endocrine-related treatment effects.
- Vulvovaginal atrophy
- Sexual function
- Breast cancer
- Endocrine therapy-related symptoms
The sponsor’s interest in this area reflects a focus on symptom burden and quality of life in oncology care.
